• Imagin Medical Inc.’s patented i/Blue System revolutionizes the way surgeons are able to visualize the bladder and identify cancers during surgery
• The breakthrough technology of Imagin Medical’s i/Blue Imaging System rectifies the limitations of both white and blue light cystoscopies
• Bladder cystoscopies first target – multiple other endoscopic procedures planned

Science and technology have continued to make striking advancements in cancer therapeutics and treatment protocols, improving upon on past successes and creating better outcomes for cancer patients. A prime example is an exciting new development in visualizing cancer during minimally invasive surgeries. Surgical imaging company Imagin Medical (CSE: IME) (OTCQB: IMEXF), is establishing a new paradigm in a doctor’s ability to “see” and surgically treat cancers. With bladder cancer as its first target, Imagin Medical’s initial product is the i/Blue Imaging™ System. The company’s patented, ultrasensitive imaging technology is based on advanced optics and light sensors and employs ultrasensitive imaging technology. Identifying potential early-stage tumors can be difficult because of the inability to distinguish between healthy tissue and tumors when viewed through a scope only using conventional white light. Cystoscopy is the conventional diagnostic procedure for visualizing bladder cancer during surgery. It allows the doctor to see inside the body with a thin, lighted, flexible tube called a cystoscope which uses white light to illuminate the bladder. White light has been used for decades and is the standard for more than 90% of the market. Like a roadmap with street signs, white light images show the full landscape of the bladder but do not effectively highlight cancer. A promising new modality, blue light cystoscopy, uses blue-filtered white light to detect flat tumors and cancerous cells not seen with white light that may be left behind during surgical removal of the tumor. However, surgeons can’t operate using blue light images. The blue images aren’t in real time, orientation in the bladder is easily lost and the surgeon must manually switch from white to blue cystoscopy and back again. Both white and blue light cystoscopies have effective uses and serious limitations in seeing the landscape of the bladder and identifying all the cancerous cells during surgery. Missing any cancerous cells poses serious concerns because they will continue to grow and spread to other parts of the bladder, a fact reflected by the recurrence rate of fifty per cent. The breakthrough technology of Imagin Medical’s i/Blue Imaging System rectifies the limitations of both white and blue light cystoscopies. By combining the white and blue light with an FDA-approved imaging agent, the i/Blue System displays side-by-side images in real-time, without the necessity to switch back and forth between the two images. Unlike any other modalities on the market today, Imagin Medical’s i/Blue Imaging System can attach to almost any endoscope model currently in use which creates a plug and play state-of-the-art system adaptable to virtually any clinical setting. Imagin Medical is advancing the i/Blue Imaging System toward commercialization. The FDA approval process is underway, and the company’s intellectual property is well-protected. Perhaps even more significant, Imagin intends to build on the i/Blue technology which will facilitate entry into multiple other endoscopic procedures. Imagin Medical is improving on past technologies and creating better outcomes for patients while even at a reduced cost. For more information, visit the company’s website at www.ImaginMedical.com. NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

• Industry’s rapid growth paired with affiliates, loyalty and gaming programs creates higher retention
• Cryptocurrency making future of online gaming secure
• Plans to go public on exchanges in Canada, UK, Europe, and the U.S.

Mobius Interactive’s co-founder and COO Robin Lawson was recently interviewed by G&M News, a global source of gaming information (https://ibn.fm/2pHJo). Specializing in Esports, sports betting, casino and live casino, Mobius is excited about the future of the industry in 2021 and beyond. Lawson discussed the company’s rapid growth, how blockchain impacts the gaming industry and future plans for the company. In September 2020, Mobius launched three brands: Mobius Bet, Aragon Casino and Club Double. Combining these brands with an affiliate platform and a full loyalty program has brought Mobius early success. The company will soon be implementing a gamification program to further empower the brands and succeed in the marketplaces they are entering. Through the affiliate program, Mobius has partnered with more than 600 VIP and master gamers. These affiliates introduce high-value players to the company’s iGaming platform. Those gamers are then provided a personalized gaming experience through the company’s real-time CRM system. Rather than focus wholly on acquisition, the company is using the loyalty and gamification programs to increase engagement. These programs have been shown to increase daily wagering up to 30% while also increasing daily player activity by 60%. Lawson went on to discuss significant changes in the online gaming community, from unprecedented growth during 2020 due to the pandemic and lockdowns to the use of blockchain and Bitcoin in the gaming industry. “We are seeing improved payments on betting with cryptocurrencies like Bitcoin, which is one of a number of crypto depositing options we offer on all of our Mobius Interactive brands,” stated Lawson. “Crypto is becoming more trusted globally. In fact, it is competing with gold right now, so I think it’s very safe to say the future for our industry is incredibly bright and we have a lot of exciting new technologies to look forward to in this field.” Over the next two years, Mobius has plans to consolidate the brands in all the regions the company enters as well as go public on exchanges such as Canada, UK, Europe and the United States. For more information, visit the company’s website at www.MobiusInteractive.Ltd. NOTE TO INVESTORS: The latest news and updates relating to Mobius are available in the company’s newsroom at http://ibn.fm/Mobius

• Autonomous security robot (“ASR”) developer Knightscope is experiencing a marked growth in investment interest through its Reg A+ offering, now counting more than 20,000 private financial backers
• CEO William Santana Li told interviewer IPO Edge the company has a plan to eventually go public, but continues to value the backing of police officers, federal law enforcement officers, corporate security officers and investment bankers with skin in the game
• The ASRs utilize artificial intelligence to monitor client properties and machine learning tools to successfully navigate during their patrols, with indoor and outdoor models available
• Knightscope’s ASRs help minimize risks to human personnel of physical harm, tedium and infection during the ongoing pandemic

Security robot manufacturer Knightscope rolled out its first autonomous product in 2015 and has watched its fanbase steadily grow during the years since then, topping 20,000 investors in February following a quick burst of new energy on the public involvement front.

During a virtual fireside interview with IPO Edge in December (when Knightscope was still reporting investors at the 17,000 level), CEO William Santana Li explained the importance of the company’s Reg A+ offering that allows Knightscope to attract private investments between $500 and $10 million online without launching a public IPO, although the company maintains a plan to go public eventually (https://ibn.fm/GsMB1). You can read about what the Company can legally say at this time about a public listing here.

“Do you know who our investors are? NYPD detectives, FBI, CIA, DHS, investment bankers, recruiters, great legal minds, chief security officers of major corporations, vice presidents of leasing of major malls and REITs. … They’re financially motivated to help the company,” Li said.

“Folks that look at this and they’re like, ‘Ah, you did this equity crowdfunding type of stuff,’ like in a negative type of way. And I’m like, ‘You know, what do you think Goldman Sachs and Morgan Stanley do all day? Someone files an S1 and what is that? That is one massive global equity crowdfunding exercise to get every Tom, Dick and Harry to write a check,” Li added. “If you look at the mission, you’re trying to secure the entire U.S. and you’re serious about it, do you really think four VCs sitting in a room, worried about all the wrong things, is how you’re going to change the world? You’re going to have to do this piece by piece and you’re going to need a lot of support.”

Knightscope’s strategy is to deliver autonomous security robots (“ASRs”) that harness A.I. developments, giving them the capacity to monitor broadcasts, thermal signatures and physical surroundings in 360-degree environments while recording what they detect and reporting it back to a monitoring center.

The company promotes its sentries’ ability to patrol facilities indoors and outdoors on a 24/7 basis 365 days a year, removing humans from front-line interactions until it’s necessary for them to intervene and thereby minimizing some of the hazards arising from armed confrontations, tedium and contagion during the currently ongoing pandemic.

Li acknowledged that there have been hurdles to overcome along the way and that everything has not gone perfectly, but also noted that the company’s robots have been popular enough that clients often have naming ceremonies to welcome the newest robotic members of their personnel teams and that members of the public have sometimes been known to hug or kiss them.

“Henry Ford (the founder of the Ford Motor Company and chief developer of the assembly line that drove mass production techniques) once stated, ‘If I had asked people what they wanted, they would have said faster horses.’ Sometimes you just have to create something all new that’s never been done before,” Li says in an investor relations video on the company’s website (https://ibn.fm/ZWM5b). “We’re blazing that new trail in law enforcement, physical security and public safety.”

The company’s robots are operating across the country’s five continental time zones, and Li noted in the fireside interview that the company has arrived at a point in its history where “every issue that we’ve got in the building we can fix with people, cash and time.” While some competitors have arisen over the years and more may yet arise, Li said, “At this point, I think we’re the worldwide leader and hope to maintain that leadership.”

For more information, visit the company’s website at www.Knightscope.com.

Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO.

DISCLAIMER: You should read the Offering Circular and risks related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• Company announced discovery of high-grade silver mineralization at Grauer Wolf target
• Excellon continues to develop and test new targets along the 36-kilometer strike length
• EXN advancing a precious metals growth pipeline in Idaho, Mexico and Germany

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2), a silver and base metals producer with operations in Mexico and precious metal exploration projects in Mexico, Idaho and Germany, has announced a new discovery. The discovery of high-grade silver mineralization comes at Grauer Wolf, the fourth target drilled at EXN’s Silver City project (https://ibn.fm/1vKtG). According to the announcement, the discovery is located on a geological site with little historical mining and adds a fourth priority area for follow-up in the 2021 drilling program at Silver City. With eight holes still outstanding, there is strong potential for additional discoveries in parallel strikes. The company is in the process of planning and preparing for more extensive drilling for its Bräunsdorf, Reichenbach, Peter Vein and now Grauer Wolf projects. Excellon is focused on advancing a precious metals growth pipeline through exploration and development of projects that include:

• Platosa — 11,000 hectares hosting the highest-grade silver mine in Mexico and 100% owned by EXN (https://ibn.fm/vCZjs)
• Kilgore — 6,788 hectare high-quality gold development project in Idaho and 100% owned by EXN (https://ibn.fm/StydP)
• Silver City — high-grade epithermal silver district in Saxony, Germany with the option to own 100% (https://ibn.fm/N8Jm9)

The 16,400-hectare Silver City project has been mined for 750 years. Records indicate high-grade silver production in excess of 1,000 g/t was mined throughout the area. Mining slowed to a standstill in the late-19th century after Germany dropped the silver standard in 1873 and the gold/silver ratio skyrocketed when silver prices plummeted. EXN is the first modern-day exploration program to focus on precious metals throughout the area, and the company is already seeing promising results. Thanks to this new discovery, Grauer Wolf is now the fourth priority area for follow-up in the Silver City 2021 drilling program. Lesser known and located 1.5 kilometers north of the Reichenbach target, Grauer Wolf is a relatively unexploited mafiac volcanic contact. EXN continues to develop and test new targets along the Silver City Project, a 36-kilometer strike length on the Bräunsdorf license that historical records indicate has produced at least 882 tonnes of silver as well as zinc and lead (https://ibn.fm/dfDzR). Many of the vein systems under this license have only been mined at shallow depths leaving the potential for many new discoveries. Excellon’s vision is to create wealth by realizing strategic opportunities through discipline and innovation for the benefit of its employees, communities and shareholders. The company also aims to continue capitalizing on current market conditions by acquiring undervalued projects. For more information, visit the company’s website at www.ExcellonResources.com. NOTE TO INVESTORS: The latest news and updates relating to EXN are available in the company’s newsroom at https://ibn.fm/EXN

• UEC president CEO Amir Adnani is featured on a recent episode of Bell2Bell Podcast.
• Adnani notes that Uranium Energy Corp. is focused on rebuilding, restarting a domestic infrastructure to mine uranium for carbon-free nuclear energy.
• The Company’s production area in the Burke Hollow project is the newest, largest ISR well field being developed in the country.

Uranium Energy (NYSE American: UEC) president and CEO Amir Adnani was featured on a recent episode of The Bell2Bell Podcast (https://ibn.fm/6mYtD), a podcast series focused on providing informative updates and exclusive interviews with executives leading companies that are operating in fast-moving industries. Under Adnani’s guidance, Uranium Energy advanced from concept to U.S. production in its first five years of operation; UEC currently has an extensive pipeline of low-cost, near-term production projects.

“Uranium Energy Corp. is a U.S.-focused developer of uranium projects using the low-cost and environmentally friendly in-situ recovery (‘ISR’) method,” said Adnani during the podcast as he provided an overview of the company’s business model. “In South Texas, we have our hub and spoke strategy. This is anchored by our fully licensed Hobson Processing Facility, one of only a few uranium processing plants in the country. We have a number of projects . . . which will be a source of U.S.-mined uranium.”

In addition to discussing the company’s business model, Adnani touched on recent company news, specifically talking about the company’s plans moving forward as the United States looks to decrease its reliance on carbon-based fuels. “Uranium is used for generating electricity in nuclear power plants, and 55% of U.S. carbon-free energy comes from nuclear power,” he said, noting that almost all of the uranium currently needed in the country to fuel reactors is coming from foreign sources.

“We have completely lost the ability to mine uranium in the U.S. from domestic sources,” he continued. “You and I both know the importance of local sources of vital needs, be it energy sources, be it masks, be it pharmaceuticals. So what we’re trying to do is to really rebuild and restart the domestic foundation to mine uranium — the fuel that is needed to run our 94 reactors in this country.”

During the interview, Adnani talked about the federal government’s bipartisan support of a U.S. Uranium Reserve and the allocation of funds to purchase uranium produced by U.S. mines, noting that he’d never seen such a move in his extensive experience in the industry. “[UEC] is getting ready to supply uranium to the global market and this new U.S. reserve,” he noted, pointing to the company’s Burke Hollow project, located in Texas. Burke Hollow’s initial production area is the newest and largest ISR well field being developed in the country (https://ibn.fm/6Br4k).

“We need to have a foundation to mine uranium domestically in the United States,” Adnani stated. “We’re rising to that occasion as a company. As a company we are today, at our Burke Hollow project… currently building one of the largest production areas currently in the United States…We have rigs on the property, we’ve got local staff, our team. We’re hiring locally. We’re creating jobs and adding to the economic development of the local communities that we’re in, in Texas…These are incredible opportunities, because not only are we creating local jobs…we’re also tying it back to developing the ability to mine uranium domestically. And again, this dovetails strategically with our plans to be a key supplier to the U.S Uranium Reserve.”

Adnani also talked about the strength of the company’s portfolio, which includes projects in Texas, Wyoming, New Mexico, Colorado and Arizona, as well as Canada and Paraguay, noting that the company looks to be ideally positioned as the market looks to expand and grow.

Uranium Energy Corp. is a U.S.-based uranium mining and exploration company that controls one of the country’s largest historical uranium exploration and development databases. Founded in 2003, UEC is headquartered in Corpus Christi, Texas.

For more information, visit the company’s website at www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

• Studies confirm natural active ingredient, which is in MustGrow’s biopesticide, has a positive impact on soil health
• Soil micro-organisms play crucial role in soil fertility, plant health
• MustGrow’s safe, effective natural biopesticide is plant based, derived from the mustard seed’s natural defense mechanism

MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has released study findings that confirm that the active ingredient in its mustard plant-based technology actually has a positive impact on soil health (https://ibn.fm/uLwuc). The studies have found that an application of the natural ingredient Allyl Isothiocyanate (“AITC”) returns organic plant material to the soil and contributes to the environmental and ecological security of the plant-based food supply as well as the planet generally.

“The active ingredient, AITC, in MustGrow’s mustard plant-based technology is perfect for use in modern, more sustainable pest control strategies,” said MustGrow scientific advisor Dr. Matthew J. Morra. “A biopesticide that is effective, dissipates quickly, leaves no harmful residues, and once gone, improves the soil ecosystem.” A professor emeritus of soil biochemistry at the University of Idaho, Morra is a leading world expert on products derived from oilseeds; he also has impressive expertise in developing mustard-based biopesticides.

Highlights from the study, which was separate from MustGrow, indicate that an application of AITC returns organic plant material to the soil, improves the environmental and ecological security of the planet, and creates a healthy microbial ecological environment for soil, which increases beneficial bacteria. In addition, AITC dissipates from the soil quickly, thereby eliminating any potential long-term toxicity to microorganisms.

The potential impact of MustGrow’s biopesticide on the soil cannot be overlooked. Soil micro-organisms play a crucial role in soil fertility and plant health. The use of synthetic chemicals in soil fumigation has been proven to harm beneficial micro-organisms, fungi and bacteria in the soil, actually creating a negative impact on soil fertility, plant health and nutrient transformation. So the now-verified positive impact that AITC has on soil is significant. Studies and research done on AITC have consistently concluded that the ingredient has a positive effect on the environmental and ecological security of the planet.

MustGrow’s remarkably safe and effective natural biopesticide is plant based, derived from the mustard seed’s natural defense mechanism to control diseases, pests and weeds with an organic food-grade biopesticide. The product is applied to the soil before seeds are planted. There is a growing interest in safe, effective, and plant-based biopesticides as farmers, consumers and investors alike become more aware of and committed to natural alternatives to synthetic chemical pesticides.

An agriculture biotech company, MustGrow is focused on providing natural, science-based biological solutions for high-value crops such as fruits and vegetables. The company is ideally positioned to leverage the growing momentum favoring alternatives to synthetic chemicals. As global agriculture looks to move closer to sustainable ways of boosting yields and crop protection, MustGrow continues to position itself as an essential part of the food landscape of the future with its mustard plant-based biopesticide.

For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF

• Pure Extracts is preparing to deliver shipment of 85% pure CBD distillate
• Company proud of quality offering produced in world-class facility
• PULL uses proprietary state-of-the art, sub-critical/super-critical CO₂extraction system

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, has signed a contract for its first CBD oil commercial sale on the wholesale market (https://ibn.fm/92kPG). Pure Extracts is preparing to deliver the first of what it anticipates will be multiple shipments this year of its 85% pure CBD distillate under this contract. “We are excited to have completed our first commercial order, and we are proud of the quality of distillate that our extraction team has produced in our new, world-class facility,” said Pure Extracts CEO Ben Nikolaevsky. According to a recent update, Pure Extracts finished construction of its state-of-the-art facility last year (https://ibn.fm/B65HW). Located about 20 minutes north of Whistler, British Columbia, the center is built to European Union GMP standards and is the perfect complement to Pure Extracts’ Standard Processing License, which the company received from Health Canada on September 25, 2020 through its wholly owned subsidiary, Pure Extracts Manufacturing Corp. Pure Extracts is gaining a reputation for providing exceptionally pure THC and CBD full spectrum oil (“FSO”) and distillate. The company obtains such a high-quality offering by using its proprietary state-of-the art, sub-critical/super-critical CO₂ extraction system. The distillate is ideally suited for use in most cannabis 2.0 products, including beverages, edibles and vape pens. With such a high-quality product available, it is perhaps no surprise that the company is seeing success in the toll processing and white labeling space. Pure Extract offers the ideal solutions for LPs that lack the extraction expertise and requisite equipment to manufacture their own raw materials. In addition, Pure Extracts is also developing its own private label of products; the Pure Pulls and Pure Chews brand, which will include vape pens and edibles, will incorporate the company’s own full spectrum THC and CBD-based extracted oils. In conjunction with the company’s commitment to strengthen its brand awareness and expand into new spaces, Pure Extracts is teaming up with Native Ads Inc. and Winning Media to create and execute digital advertising campaigns. Under the terms of the agreement, Native Ads and Winning Media will provide strategic digital media services, marketing coordination, content production and data analytics services — all designed to support Pure Extracts as it moves forward with its strategic growth and expansion plans. Pure Extracts Technologies Inc., headquartered in Pemberton, British Columbia, is a plant-based extraction company with a new vertical in functional mushrooms with plans the enter burgeoning psychedelic mushroom sector once it receives a Dealer’s Licence from Health Canada. A Dealer’s Licence would allow the company to handle, manufacture and sell substances such as psilocybin and psilocin. The company is positioned to be the dominant extraction company and a leader in the rapid development and commercialization of functional and medicinal psychedelic products. For more information, visit the company’s website at www.PureExtractsCorp.com. NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

• UME is trusted supplier of FDA-approved antibody, antigen test kits
• United moved quickly to address growing needs created by COVID-19
• Company dedicated to providing guidance to aging population, their families and medical staff supporting them

United Medical Equipment Business Solutions Network is a company focused on the needs of aging patients and veteran communities as well as those impacted by the COVID-19 pandemic. United is a trusted supplier of FDA-approved antibody and antigen test kits, medical equipment and personal protective equipment (“PPE”). As the world attempts to control this pandemic, it is essential to quickly identify who is infected and who has already been infected. Antibody testing determines whether or not a patient has had COVID-19 in the past while antigen testing determines whether or not a patient currently has COVID-19.

An antibody test can help determine how many people have had and recovered from COVID-19. This includes those that were asymptomatic. Since individuals are presenting various symptoms, ranging from no symptoms to full respiratory failure, symptoms alone cannot accurately confirm if someone has been infected. Antibody tests have limited use in detection but help to determine accurate case numbers and research into immunity.

The antigen rapid test allows for quick diagnosis that can help curb the spread of the virus. Antigens are a specific protein that sits on the surface of the virus. These rapid tests identify antigens when the individual is contagious. That individual can then be placed into quarantine, stopping the spread of the virus (https://ibn.fm/xB6J7).

The FDA-approved CareStart(TM) COVID-19 Antigen Rapid POC test is part of United’s answer in combating the spread of the virus. The test is administered by medical professionals to detect COVID-19 antigens. This test identifies acute infection with 88.4% sensitivity and 100% specificity, and helps provide critical answers about active infections to patients and healthcare workers alike (https://ibn.fm/Q8js4).

United moved quickly to address the growing needs created by the COVID-19 pandemic. In addition to providing test kits, COVID-19 supplies and products (https://ibn.fm/KgD8i), and PPE equipment with flexible payment options, the company has acted as a trusted senior referral source for independent living, assisted living, hospice, memory care, skilled nursing and senior care centers.

Throughout 2020 and into 2021, the elderly have been particularly vulnerable to this pandemic. United is dedicated to providing guidance for the aging population, their families, and the medical community that serves them.

For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

• TAAT(TM) partnered with CROSSMARK based on powerful formula for creating, implementing and executing strategies for CPG merchandising
• Of particular interest is CROSSMARK’S success in commercializing tobacco alternatives that achieved dominant e-cigarette market share
• TAAT committed to growing innovative tobacco-free, nicotine-free alternative to traditional cigarettes

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF), a life science company dedicated to giving legal-aged smokers a nicotine- and tobacco-free smoking experience, recently unveiled TAAT(TM), its flagship product — and the product has been greeted with an exceptional response. Representative of the interest shown in the product — and the promising future of the innovative smoking alternative — is the agreement TAAT recently signed with CROSSMARK, an omnichannel CPG sales agency. “Ever since TAAT was first placed on store shelves in Ohio in December 2020, we have received glowing feedback about the product from both legal-aged smokers and retailers alike,” said TAAT CEO Setti Coscarella. “It is common knowledge in the world of business that this is only the first step towards the success of a product launch. We selected CROSSMARK to represent TAAT because their formula for creating, implementing and executing strategies for CPG merchandising has been honed over decades of bringing new consumer products to mainstream retail channels.” Through CROSSMARK, all three TAAT varieties — Original, Smooth and Menthol —may be available at more than 100,000 convenience stores located throughout the country. CROSSMARK, a sales and merchandising agency for CPG products, has established relationships with major retailers across all channels. Of particular interest to TAAT is CROSSMARK’S success in commercializing tobacco alternatives that achieved dominant e-cigarette market share in the United States. “At CROSSMARK, we pride ourselves in our familiarity with what intrigues today’s consumers and what consistently delivers value to them,” said Jeff Neihart. CROSSMARK vice president and general manager of customer service. “We are very selective in onboarding only a limited number of new brands each year, and it gives me great satisfaction to have found a match in TAAT as a novel, relevant, and ‘sticky’ product that could continue to resonate well with legal-aged smokers. “Furthermore, we are confident that with the combination of our presence in the retail channels through which tobacco products are sold and our experience in executing strategies within the category of tobacco alternatives, we can amplify the value proposition offered by TAAT to legal-aged smokers in the United States and help the company meet or exceed their goals,” Neihart continued. “CROSSMARK has been in the business of connecting retailers with a curated range of CPG products for more than 100 years, and we are excited to introduce TAAT to tobacco retailers who we predict will find the product appealing and will want to carry it in their respective stores.” According to the agreement, in addition to introducing TAAT to potential wholesale and retail locations, CROSSMARK will provide an in-field execution team focused on supporting in-store acceptance, merchandising and reorders of TAAT products. The company will also provide TAAT with extensive promotional, trade marketing and analytics support as the two companies partner together to make the most of existing initiatives and evaluate the possibilities for national growth and expansion. “In addition to leveraging their relationships with major retailers and wholesalers across our targeted channels for TAAT, CROSSMARK also offers an impressive suite of ‘back office’ functions including marketing, data analytics, and order processing support,” said Coscarella. “Altogether, these services could enable TAAT to penetrate the tobacco market much more rapidly and efficiently compared to building out our own national sales and merchandising team from scratch. One only has to look at the results CROSSMARK achieved in commercializing another tobacco brand across the United States to know that they have both the experience and know-how to launch a product to an audience of legal-aged smokers, which could assist the company in realizing its objectives for the TAAT product launch. We are thrilled to have CROSSMARK on our side as we seek to make TAAT products available to legal-aged smokers throughout the United States.” TAAT has developed TAAT, a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched in the United States in Q4 2020 and is focused on positioning itself in the $814 billion global tobacco industry. For more information, visit the company’s website at www.TAATGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

• Industry experts expect rare earth elements (“REE”) space to continue to grow significantly through 2030
• UUUU entered REE business last year to complement its core uranium production; plans commercial production of intermediate REE product in H1 2021
• Company expects to become leading U.S. player in this field, supplying up to 50% of nation’s rare earth demand in next few years

The rare earth elements (“REE”) market continues to be of interest for investors and governments around the world amid the heightened uncertainty due to trade restrictions out of China and increased demand for REE magnets, according to an article published by “Investing News Network” (https://ibn.fm/HfbHa). The sector provides the critical metals required for clean energy technologies and electronics that penetrates many segments of both the consumer and business spaces. As the country’s largest uranium producer and the leading critical minerals producer, Energy Fuels (NYSE American: UUUU) (TSX: EFR) has entered the REE space, committed to domestically supplying another critical mineral needed to making the new Biden Administration’s clean energy goals a reality.

After the initial hit to prices in the first half of 2020 as lockdowns and containment measures in China impacted the global supply chains, the REE space rebounded strongly in the second half of the year. And it appears that the sector’s growth will not stop there.

REEs, used in many tech devices and clean energy technologies such as smartphones, wind turbines and electric vehicles, will be critical for the sector over the next decade. Although REE’s supply and demand dynamics are still uncertain due to the pandemic, most analysts are optimistic for 2021 and beyond.

The push for the sector comes as Western countries continue to create supply chains less dependent on China. The article cites David Merriman of Roskill, a commodity research firm, who expects electric and hybrid vehicles’ drivetrains and wind turbine — which all use rare earth permanent magnets — to drive the sector’s robust growth for the remainder of the decade. For example, it is expected that REE demand for automotive applications will grow around 26.5% year-on-year in 2021.

Adamas Intelligence, a research firm focused on strategic metals and minerals, also expects demand to bounce back for nearly all end-use categories for rare earth elements in 2021. Global passenger battery EV, plug-in hybrid EV and hybrid EV sales are expected to drive the growth, increasing collectively by 20 to 40% year over year.

In April 2020, UUUU set out to penetrate the REE market as a complement to its core uranium product lines. Since the announcement of the expansion into REE business, the company has made significant strides, quickly becoming an emerging player in the space. Its initial goal is to enter the commercial REE business in H1 2021 and to supply up to 50% of U.S. rare earth demand contained in a mixed REE concentrate over the next few years.

The company also has plans to install REE separation, and perhaps additional downstream capabilities, over the next few years. The ambitious plans are to be achieved with the company’s existing infrastructure (https://ibn.fm/XhQAQ). With its expansion into the growing REE market and all debt paid off last year, the company is leveraging a robust business model that allows it to be well positioned to capitalize on the increasing momentum for the REE space.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU